Exosomes & Microbiome in Cosmetics: Evidence Grades and Claim Boundaries (2025)
Exosomes and the microbiome are two pillars of next-gen K-beauty, but their regulatory weight moved in opposite directions. Korea expanded ‘exosome’ to a prohibited cosmetic ad expression in 2025 and bans human-derived cells and tissues as ingredients, while the microbiome is settling into a postbiotic-led barrier-and-soothing concept.
Read more →PDRN in Cosmetics: Efficacy Evidence vs. Claim Boundaries
PDRN draws attention from tissue-repair research and injectable/medical-device use, but topical cosmetics cannot make medical claims like wound healing, regeneration, or anti-inflammatory treatment. Brands should work within cosmetic claim ranges — hydration, firmness, skin texture, soothing support — while aligning ingredient stability, labeling evidence, and export rules.
Read more →5 K-Beauty Ingredient Trends to Watch in 2026
In 2026, K-beauty centers on barrier repair (ceramides, panthenol), microbiome ferments, low-irritation exosomes, PDRN salmon-DNA, and upcycled naturals. Here are the five ingredient directions global buyers ask for most.
Read more →